이창한, CHANG-HAN LEE, Ph.D.

CHL_photo_edited.png

Assistant Professor
Department of Pharmacology at Seoul National University College of Medicine
Department of Biomedical Sciences at Seoul National University College of Medicine
SNU Hospital
SNU Dementia Research Center
​SNU Bio-Max Institute

Wide River Institute of Immunology (WRII) SNU

Office: #614 at Basic Science Research Building
Lab: #423 at Basic Science Research Building
Email: chlee-antibody@snu.ac.kr

  Dr. Lee has studied the protein and antibody engineering. My main researches include 1) non-antibody protein scaffold based on Kringle domain, 2) engineering and discovery of antibody Fab domain to obtain antigen-binding activity, and 3) engineering of antibody Fc domain to study the immune response of antibodies or/and to maximize the therapeutic efficacy of antibodies by improving pharmacokinetics of antibody.

Education

Bachelor: ​Dept. of Chemical and Biological Engineering, Ajou University (2000.03-2007.02)

Ph.D: Dept. of Molecular Science and Technology, Ajou University (2007.03-2013.02), Advisor: Dr. Yong-Sung Kim (http://antibody.ajou.ac.kr/)

Experience

Postdoctoral research fellow: Dept of Chemical Engineering, The University of Texas at Austin (2013.03-2018.02),

Advisor: Dr. George Georgiou (http://www.che.utexas.edu/georgiou/index.html)

Research associate: Dept of Chemical Engineering, The University of Texas at Austin (2018.03-2020.02)

Career

Assistant Professor: Dept. of Pharmacology, Seoul National University College of Medicine (2020.03-)

Member of SNU Dementia Research Center (2020.05-) (http://snuadrc.com/)

Guest editor  for Special Issue: Antibody Fc Biology in Disease and Therapy at Pharmaceutics (2020.11-) 

Review editor for Frontiers in Immunology (2021.03-) & Frontiers in Bioengineering and Biotechnology (2021.04-)

​대한암예방학회 학술위원회 위원 (2021.01-)

SNU 10-10 project CDMC (http://cdbc.snu.ac.kr/bbs/board.php?bo_table=sub6_1_a)

SNU Bio-Max Institute (http://bio-max.snu.ac.kr/)